Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells
Cited by 5
Related Papers
SUMOylation disassembles the tetrameric pyruvate kinase M2 to block myeloid differentiation of leukemia cells
|Cell Death and Disease|2021|35
Mitochondrial oxidative phosphorylation is dispensable for survival of CD34+ chronic myeloid leukemia stem and progenitor cells
|Cell Death and Disease|2022|32
Pyruvate kinase M2 phosphorylates H2AX and promotes genomic instability in human tumor cells
|Oncotarget|2017|30
Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells
|Journal of Translational Medicine|2016|29
CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma
|Nature Communications|2024|7